Who are the carriers of MRSA in the community? A prospective study in the Pays de la Loire region of France

Clinical Microbiology and Infection

Volumn 16, Issue 7, 2010, Pages 915-920

  Thibaut, S ^a   Caillon, J ^b   Lepelletier, D ^b   Lombrail, P ^a   Potel, G ^a,b   Ballereau, F ^a,b  

^a NANTES UNIVERSITY HOSPITAL   (France)

^b UNIVERSITÉ DE NANTES   (France)

Author keywords

Antibiotic resistance; Community ecology; MRSA; Risk factor; Staphylococcus aureus

Indexed keywords

FUSIDIC ACID; GENTAMICIN; MACROLIDE; OFLOXACIN; OXACILLIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TOBRAMYCIN;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATION; COMMUNITY; CONTROLLED STUDY; FEMALE; FRANCE; HOSPITALIZATION; HUMAN; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; PHENOTYPE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SKIN INFECTION; SOFT TISSUE INFECTION; URINE CULTURE;

METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS AUREUS;

EID: 77954651867     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2009.02953.x     Document Type: Article

References (30)

1. Jevons P. Celbenin-resistant staphylococci. BMJ 1961, 1:124-125.
2. Merrer J, Santoli F, Appéré-De Vecchi C, Tran B, De Jonghe B, Outin H. « Colonization pressure » and risk of acquisition of methicillin-resistant Staphylococcus aureus in a medical intensive care unit. Infect Control Hosp Epidemiol 2000, 21:718-723.
3. Back NA, Linnemann CC, Staneck JL, Kotagal UR. Control of methicillin-resistant Staphylococcus aureus in a neonatal intensive-care unit: use of intensive microbiologic surveillance and mupirocin. Infect Control Hosp Epidemiol 1996, 17:227-231.
4. Boyce JM, Opal SM, Potter-Bynoe G, Medeiros AA. Spread of methicillin-resistant Staphylococcus aureus in a hospital after exposure to a health care worker with chronic sinusitis. Clin Infect Dis 1993, 17:496-504.
5. Valls V, Gomez-Herruz P, Gonzales-Palacios R, Cuadros JA, Romanyk JP, Ena J. Long-term efficacy of a program to control methicillin-resistant Staphylococcus aureus. Eur J Clin Microbiol Infect Dis 1994, 13:90-95.
6. Harstein AI, Denny MA, Morthland VH, LeMonte AM, Pfaller MA. Control of methicillin-resistant Staphylococcus aureus in a hospital and an intensive care unit. Infect Control Hosp Epidemiol 1995, 16:405-411.
7. Lepelletier D, Richet H. Surveillance and control of methicillin-resistant Staphylococcus aurous infections in French hospitals. Infect Control Hosp Epidemiol 2001, 22:677-682.
8. Quentin C, Grobost F, Fischer I. Résistance aux antibiotiques de Staphylococcus aureus en pratique de ville: étude sur six mois en Aquitaine. Pathol Biol 2001, 49:33-40.
9. Naimi TS, LeDell KH, Boxrud DJ. Epidemiology and clonality of community-acquired methicillin-resistant Staphylococcus aureus in Minnesota, 1996-1998. Clin Infect Dis 2001, 33:990-996.
10. Naimi TS, LeDell KH, Como-Sabetti K. Comparison of community- and health care-associated methicillin-resistant Staphylococcus aureus infection. JAMA 2003, 290:2976-2984.
11. Davis SL, Perri MB, Donabedian SM. Epidemiology and outcomes of community-associated methicillin-resistant Staphylococcus aureus infection. J Clin Microbiol 2007, 45:1705-1711.
12. Johnson LB, Bhan A, Pawlak J, Manzor O, Saravolatz D. Changing epidemiology of community-onset methicillin-resistant Staphylococcus aureus bacteremia. Infect Control Hosp Epidemiol 2003, 24:431-435.
13. Saiman L, O'Keefe M, Graham PL. Hospital transmission of community-acquired methicillin-resistant Staphylococcus aureus among post-partum women. Clin Infect Dis 2003, 37:1313-1319.
14. From the Centers for Disease Control and Prevention. Four pediatric deaths from community-acquired methicillin-resistant Staphylococcus aureus- Minnesota and North Dakota, 1997-1999. JAMA 1999, 282:1123-1125.
15. Gillet Y, Issartel B, Vanhems P. Association between Staphylococcus aureus strains carrying the gene for Panton-Valentine leukocidin and highly lethal necrotising pneumonia in young immunocompetent patients. Lancet 2002, 359:753-759.
16. Robert J, Etienne J, Bertrand X. Methicillin-resistant Staphylococcus aureus producing Panton-Valentine leukocidin in a retrospective case series from 12 French hospital laboratories, 2000-2003. Clin Microbiol Infect 2005, 11:585-587.
17. Oliveira DC, de Lencastre H. Multiplex PCR strategy for rapid identification of structural types and variants of the mec element in methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 2002, 46:2155-2161.
18. Lina G, Piémont Y, Godail-Gamot F. Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus primary skin infections and pneumonia. Clin Infect Dis 1999, 29:1128-1132.
19. Salgado CD, Farr BM, Calfee DP. Community-acquired methicillin-resistant Staphylococcus aureus: a meta-analysis of prevalence and risk factors. Clin Infect Dis 2003, 36:131-139.
20. Saravolatz LD, Pohlod DJ, Arking LM. Community-acquired methicillin-resistant Staphylococcus aureus infections: a new source for nosocomial outbreaks. Ann Intern Med 1982, 97:325-329.
21. Udo EE, Pearman JW, Grubb WB. Genetic analysis of community isolates of methicillin-resistant Staphylococcus aureus in Western Australia. J Hosp Infect 1993, 25:97-108.
22. Boyce JM, Cookson B, Christiansen K. Methicillin-resistant Staphylococcus aureus. Lancet Infect Dis 2005, 5:653-663.
23. Grundmann H, Aires-de-Sousa M, Boyce J, Tiemersma E. Emergence and resurgence of methicillin-resistant Staphylococcus aureus as a public-health threat. Lancet 2006, 368:874-885.
24. Diederen BM, Kluytmans JA. The emergence of infections with community-associated methicillin resistant Staphylococcus aureus. J Infect 2006, 52:157-168.
25. Ficca G, Chauvel M, de Moüy D. Etude de la prévalence de la résistance à la méthicilline chez Staphylococcus aureus communautaire. Med Mal Infect 2006, 36:207-212.
26. Dufour P, Gillet Y, Bes M. Community-acquired methicillin-resistant Staphylococcus aureus infections in France: emergence of a single clone that produces Panton-Valentine leukocidin. Clin Infect Dis 2002, 35:819-824.
27. Böcher S, Gervelmeyer A, Monnet DL, Molbak K, Skov RL. Methicillin-resistant Staphylococcus aureus: risk factors associated with community-onset infections in Denmark. Clin Microbiol Infect 2008, 14:942-948. and the Danish CA-MRSA Study Group
28. David MZ, Glikman D, Crawford SE. What is community-associated methicillin-resistant Staphylococcus aureus? J Infect Dis 2008, 197:1235-1243.
29. Deurenberg RH, Stobberingh EE. The evolution of Staphylococcus aureus. Infect Genet Evol 2008, 8:747-763.
30. Lepelletier D. Emergence de Staphylococcus aureus résistant à la méticilline dans la communauté: un nouveau challenge. Antibiotiques 2005, 7:149.